$GBT Our take on this name that the analyst community loves this week...
In today's 'deep dive' we take an in-depth look at Rocket Pharmaceuticals. Is it a Buy, Sell or a Hold?
We go deeper into the story of small cap biopharma Gemphire Therapeutics to determine if stock is a Buy, Hold or a Sell
A development biotech concern with a big approaching catalyst implying a huge upside potential.
After the first quarter earnings report and revised guidance the stock of this biotech stalward seems to have bottomed.
Today we take a look at Synlogic. This 'Tier 4' biotech concern has a deep early stage pipeline and is well-funded
Today we take a deeper look at Calithera Biosciences, a small biotech firm. It is a Buy, Sell or Hold? Find out below
Genetic testing concern Invitae rose 10% in trading on Thursday on blowout 1st quarter results. Further gains ahead?
Is this Busted IPO biotech concern a Buy, Sell or Hold?
Deep dive investment analysis of the small RNAi concern, Dicerna Pharmaceuticals, whose stock has been on the move.
#biotech Poll! Where will this high risk/high reward $9 biotech 'lottery ticket' be trading at 12 months from now $TOCA? Cast…
$CRBP The stock trades just at approximately $5.50 a share and has a market cap just north of $300 million.
Both look like they are currently oversold, have attractive risk/reward profiles and have picked up positive analyst mentions…